Skip to main content

Peer Review reports

From: Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer

Original Submission
23 Feb 2023 Submitted Original manuscript
6 May 2023 Reviewed Reviewer Report - Han Jun
21 May 2023 Reviewed Reviewer Report
29 Sep 2023 Author responded Author comments - Seong-Gyu Ko
Resubmission - Version 2
29 Sep 2023 Submitted Manuscript version 2
11 Oct 2023 Author responded Author comments - Seong-Gyu Ko
Resubmission - Version 3
11 Oct 2023 Submitted Manuscript version 3
16 Oct 2023 Author responded Author comments - Seong-Gyu Ko
Resubmission - Version 4
16 Oct 2023 Submitted Manuscript version 4
21 Oct 2023 Author responded Author comments - Seong-Gyu Ko
Resubmission - Version 5
21 Oct 2023 Submitted Manuscript version 5
12 Nov 2023 Reviewed Reviewer Report - Han Jun
25 Nov 2023 Reviewed Reviewer Report
7 Dec 2023 Author responded Author comments - Seong-Gyu Ko
Resubmission - Version 6
7 Dec 2023 Submitted Manuscript version 6
14 Dec 2023 Author responded Author comments - Seong-Gyu Ko
Resubmission - Version 7
14 Dec 2023 Submitted Manuscript version 7
Publishing
11 Jan 2024 Editorially accepted
1 Feb 2024 Article published 10.1186/s12906-024-04347-y

You can find further information about peer review here.

Back to article page